1.920USD+5.49%Mkt Cap: 41.03M $P/E: —1d ago
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, …
Industry Peers
Pharmaceutical Retailersvs Pharmaceutical Retailers
P/B
Cheaper
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap41.03M $
Enterprise Value19.50M $
Revenue (TTM)179.02M $
Gross Profit50.22M $
Net Income (TTM)-57.29M $
Revenue/Share8.557 USD
Last Price1.920 USD
Fiscal Year EndMar 2026
MR QuarterMar 2026
Employees189
CountryUS
SectorHealthcare
IndustryPharmaceutical Retailers
ISINUS7163821066
Valuation
P/E (Trailing)—
P/E (Forward)-64.00
PEG2.32
EV/EBITDA-1.03
EV/Revenue0.11
P/S0.23
P/B1.25
EPS (TTM)-2.74
EPS (Forward)-0.03
52W Range
1.57014% of range4.100
52W High4.100 USD
52W Low1.570 USD
Profitability
Gross Margin28.05%
Oper. Margin-9.32%
EBITDA Margin-10.61%
Profit Margin-32.00%
ROE-197.95%
ROA-70.56%
Growth
Revenue Growth-15.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.39M $
CapEx (TTM)4.62M $
FCF Margin-11.38%
FCF Yield-49.65%
Net Debt-20.88M $
Net Debt/EBITDA1.10
Balance Sheet
Debt/Equity0.02
Current Ratio0.84
Quick Ratio0.45
Book Value/Sh1.534 USD
Cash/Share1.018 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield6.86%
Payout Ratio0.00%
Ex-Div DateAug 11, 2023
Pay DateAug 18, 2023
Analyst Consensus
Rating—
Target (Mean)2.150 USD
Upside (mean)+12.0%
Target Range2.150 USD – 2.150 USD
# Analysts1
Ownership
Shares Out.21.37M
Float13.56M
Insiders16.38%
Institutions44.64%
Short Interest
Short Ratio3.0d
Short % Float3.89%
Short % Out.2.87%
Shares Short612.31K
Short (prev mo.)579.29K
Technical
SMA 502.081 (-7.7%)
SMA 2002.526 (-24.0%)
Beta0.77
S&P 52W Chg20.05%
Avg Vol (30d)1.23M
Avg Vol (10d)2.83M
Technical Indicators
RSI (14)51.1
MACD-0.0731
MACD Signal-0.0980
MACD Hist.+0.0248
BB Upper2.013 USD
BB Middle1.808 USD
BB Lower1.602 USD
BB Width22.78%
ATR (14)0.1313 USD
Vol Ratio (20d)3.20x